Ocugen CEO to Present at Prestigious BIO CEO & Investor Conference


MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a frontrunner in the biotechnology industry, announced that its Chairman, Chief Executive Officer, and Co-Founder, Dr. Shankar Musunuri, will present at the highly anticipated BIO CEO & Investor Conference. The conference will take place on February 26-27, 2024, at the Marriott Marquis in New York City.

The BIO CEO & Investor Conference is a significant event in the biotechnology industry’s calendar, attracting investors and leading pharmaceutical companies from around the globe. Participants are eager to discover new investment opportunities and learn about the latest advancements in the field.

Dr. Musunuri’s presentation is set to take place on Monday, February 26, at 1:45 p.m. ET in the Plymouth Room of the Marriott Marquis. This offers a unique opportunity for Ocugen to showcase its pioneering work in gene and cell therapies, biologics, and vaccines, and to discuss its business and clinical development strategy, recent corporate achievements, and anticipated milestones.

In addition to Dr. Musunuri’s presentation, other members of Ocugen’s leadership team will conduct one-on-one meetings with registered investors and pharmaceutical companies. These interactions will provide an opulent platform for Ocugen to further establish its position in the biotech industry and to potentially forge new alliances and partnerships.

Ocugen’s participation in the BIO CEO & Investor Conference aims to highlight its commitment to innovation and progress in the biotech space. With a focus on developing novel treatments for retinal diseases, infectious diseases, and orthopedic ailments, Ocugen is working towards addressing unmet medical needs and improving global health.

The company’s breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, demonstrating the kind of innovative thinking that propels the biotech industry forward. Its advancements in research for infectious diseases and orthopedic conditions further exemplify Ocugen’s dedication to addressing public health concerns and meeting medical needs.

READ:  Ocugen CEO to Highlight Gene Therapy Advances at Healthcare Equity Conference

Attendees interested in scheduling a meeting with the Ocugen leadership team are encouraged to register through the BIO CEO attendee portal. As one of the most important events in the biotechnology industry, the BIO CEO & Investor Conference provides a platform for companies like Ocugen to showcase their work, share insights, and engage with potential investors and partners. With its focus on innovation and commitment to improving global health, Ocugen is certainly a company to watch at this year’s conference.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.